Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 3 of 1012345...10...Last »

European regulator recommends approving GSK injectable asthma drug

GlaxoSmithKline Plc said the European health regulator had recommended approving its injectable drug to treat asthma patients who don’t respond well to traditional inhalers. The European Commission is expected to decide on a final approval for the drug before the end of 2015. The European Medicines Agency’s Committee for Medicinal Products for Human Use gives […]

Read More »

Novartis launches portfolio for low and low-middle-income countries

Novartis AG launched a portfolio of 15 medicines to treat chronic diseases in low- and low-middle-income countries, the drugmaker said in a statement on Thursday.   The Basel-based company said ‘Novartis Access’ will be launched first in Kenya, Ethiopia and Vietnam, with expansion to eventually include 30 countries. Novartis said the portfolio addresses cardiovascular diseases, […]

Read More »

Nobel Prize predictions see honors for gene editing technology

Scientists behind the discovery of a technology called CRISPR-Cas9 that allows researchers to edit virtually any gene they target are among the top contenders for Nobel prizes next month, according to an annual analysis by Thomson Reuters. The predictions announced on Thursday come from the Intellectual Property & Science unit of Thomson Reuters (which also […]

Read More »

Pfizer’s Sayana Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection

Builds on Current Momentum Towards Broadening Access to This Contraceptive Option for Women Across the Globe   September 24, 2015 12:01 AM Eastern Daylight Time   NEW YORK–(BUSINESS WIRE)–Pfizer Inc. announced today that the company’s injectable contraceptive, Sayana® Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for administration by self-injection. […]

Read More »

Weight-loss surgery may not increase health costs for diabetes

(Reuters Health) – Weight loss surgery may be a cost-effective way of lowering blood sugar for many diabetics, not just those who are severely obese, a Swedish study suggests.   Researchers found that for people with diabetes, total healthcare costs did not rise in the years following weight-loss surgery, largely because of overall savings from […]

Read More »

Non-antibotic drug shows promise in deadly C. difficile infections

A non-antibiotic drug already tested in people for other uses may be active in treating Clostridium difficile, a superbug that preys on people whose protective gut bacteria have been wiped out by antibiotics. Studies in mice by researchers at Stanford University School of Medicine showed that the drug ebeselen, a compound being studied in clinical […]

Read More »

Steep discounts help biotech drug copies gain ground in Europe

LONDON (Reuters) – Cut-price versions of expensive biotech drugs are gaining ground in Europe, following surprisingly steep price discounts offered on the first copy of a complex antibody medicine for rheumatoid arthritis and Crohn’s disease. The potential for so-called “biosimilars” to take business from pricey original brands is grabbing the attention of both healthcare providers, […]

Read More »

Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215

Study Evaluated Efficacy and Safety of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-small Cell Lung Cancer Primary Efficacy Analysis Demonstrates Clinical Equivalence; Safety, Immunogenicity Comparable to Bevacizumab   THOUSAND OAKS, Calif. and DUBLIN, Sept. 23, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced a Phase 3 study […]

Read More »

OncoGenex’s pancreatic cancer drug found ineffective in study

(Reuters) – Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was not effective in a mid-stage study. The intravenous drug, apatorsen, when added to Celgene Corp’s combination treatment of Abraxane and chemotherapy drug gemcitabine, did not show any survival benefit when compared with the Abraxane combination alone, OncoGenex said. The […]

Read More »

Nestle pushes further into medicine with planned Alzheimer’s test

ZURICH (Reuters) – Food group Nestle has taken a further step into the medicine business by signing a research collaboration agreement with a Swiss biotech company to develop an Alzheimer’s disease diagnostic test. Nestle’s second medical deal in a week underscores the commitment by the world’s largest packaged food company to the faster-growing, more profitable […]

Read More »

U.S. drugmaker Turing to roll back 5,000 percent price hike

(Reuters) – Turing Pharmaceuticals, a small company that generated outrage over raising the cost of an old anti-infective drug by more than 5,000 percent, said on Tuesday it would roll back that increase to make sure it remains affordable. Turing Pharmaceuticals, a small company that generated outrage over raising the cost of an old anti-infective […]

Read More »

Heron Therapeutics Reports Positive Top-Line Results from Phase 2 Study of HTX-011 in the Management of Post-Operative Pain

-Pain intensity through 24 hours reduced by 69%-Pain intensity through 72 hours reduced by 40%-Time to first use of opiate rescue medication increased by 488%-32% of patients received no opiate rescue through 72 hours compared to 5% for placebo   REDWOOD CITY, Calif.–(BUSINESS WIRE)–Heron Therapeutics, Inc. (NASDAQ: HRTX), a biotechnology company focused on improving the […]

Read More »

Bridging The Value Chain – The Pedigree Way

By Arun Ramesh, Lead Analyst, Beroe Inc.   Abstract 1 Serialization – Need of the HourLack of global co-operation on agreement with one common technology over the years has delayed the process of serializing the drugs. By and large, majority of the regions have come up with consensus to have a Unique level Identification Code […]

Read More »

IS THAT THE DRUGS TALKING?

A real-life experiment in brand communications By Dave Sonderman, executive creative director of GSW Worldwide, an inVentiv Health company. http://wespeakpeople.com   If other brands communicated with customers the way healthcare brands do, how many customers would they have? Or lose? More than 90 million Americans fail to act on important health information each year due […]

Read More »

Taiho Oncology Inc. Announces FDA Approval of LONSURF (trifluridine and tipiracil) for Refractory Metastatic Colorectal Cancer (mCRC)

LONSURF represents the first FDA-approved product for Taiho Oncology, setting the stage for the company’s oncology pipeline   PRINCETON, N.J., Sept. 22, 2015 /PRNewswire/ — Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration (FDA) approved LONSURF® (trifluridine and tipiracil), formerly known as […]

Read More »

Reforms needed to address medical diagnostic errors: U.S. report

Most Americans will fall victim to at least one diagnostic error in their lifetime, and when this occurs, it often can be deadly, according to a new report released on Tuesday by the Institute of Medicine, which advises the U.S. government and policymakers. The report called for greater emphasis on improving diagnoses in the United […]

Read More »

FDA advisers to weigh concerns over Bayer’s Essure contraceptive

U.S. health experts will review the potential risks of Bayer AG’s permanent contraceptive device, Essure, on Thursday in light of growing complaints over possible side effects, and consider whether its use should be restricted.   The Food and Drug Administration made public on Tuesday the questions it would like addressed by an advisory panel of […]

Read More »

Exclusive: Americans overpaying hugely for cancer drugs – academic study

Americans are paying way over the odds for some modern cancer drugs, with pharmaceutical companies charging up to 600 times what the medicines cost to make, according to an independent academic study. The United States also pays more than double the price charged in Europe for these drugs – so-called tyrosine kinase inhibitors (TKIs), a […]

Read More »

AstraZeneca PLC Makes Large Data Set Available to Outside Scientists to Find Cancer Drug Cocktails

LONDON – AstraZeneca will release preclinical data from more than 50 medicines in an effort to find new cancer treatments as part of a new challenge to tap the minds of researchers and clinicians across the globe. AstraZeneca’s decision is part of a crowd-sourcing effort to accelerate the development for “synergistic tumor-fighting drug combinations,” Reuters […]

Read More »

Craig Venter’s company in deal for whole exome tests at new low cost

A company formed by genome pioneer Craig Venter will offer clients of a South Africa-based insurance company whole exome sequencing –sequencing all protein-making genes in the human genome – at a price that marks yet another dramatic decline in the cost of gene sequencing, the two companies said on Tuesday. Venter’s company, Human Longevity Inc, […]

Read More »

Page 3 of 1012345...10...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!

Subscribe

Ad Right Bottom

Main Navigation